In lung adenocarcinoma, mutations in the V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS) are observed over 33% of cases, and 45 600 new lung cancer diagnoses annually in the USA contain the four most common KRAS mutant alleles [53,54]. This evidence concerns the gene KRAS and lung carcinoma.